Orient Pharma Co., Ltd. (TPEX:4166)
Taiwan · Delayed Price · Currency is TWD 24.00
+0.10 (0.42%)
Aug 19, 2026, 1:30 PM CST
Orient Pharma Market Cap
Orient Pharma has a market cap or net worth of 5.33 billion as of August 19, 2026. Its market cap has decreased by -24.37% in one year.
Market Cap
5.33B
Enterprise Value
4.93B
Revenue
1.52B
Ranking
n/a
PE Ratio
24.29
Stock Price
24.00
ChartMarket Cap Chart
Since June 15, 2012, Orient Pharma's market cap has increased from 4.12B to 5.33B, an increase of 29.51%. That is a compound annual growth rate of 1.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 5.33B | -8.60% |
| Dec 31, 2025 | 5.83B | -27.36% |
| Dec 31, 2024 | 8.03B | 80.00% |
| Dec 29, 2023 | 4.46B | 14.13% |
| Dec 30, 2022 | 3.91B | 11.76% |
| Dec 30, 2021 | 3.50B | 28.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Standard Chemical & Pharmaceutical | 10.99B |
| Alar Pharmaceuticals | 6.71B |
| Formosa Laboratories | 6.29B |
| SCI Pharmtech | 6.25B |
| Panion & Bf Biotech | 5.00B |
| LIWANLI Innovation | 4.33B |
| Tien Liang BioTech | 4.22B |
| Orient EuroPharma | 4.16B |